07 May SAHPRA Statement on the ANHP Judgement
EKATERINA BOLOVTSOVA via Pexels...
SAHPRA Tag
03 May SAHPRA Comments on ACDP court matter on vaccines for minors
03 May 2022 Embargo: Immediate release Pretoria, 3 May 2022 - In October 2021, the African Christian Democratic Party (ACDP); Free the Children -Save the Nation NPC, Caring Healthcare Workers Coalition NPC, and the COVID Care Alliance NPC initiated court action against the Minister of Health and...
19 Apr SAHPRA Responds to the ANHP Judgement
20 April 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) notes the ruling by the Supreme Court of Appeal (SCA) in favour of the Alliance of Natural Health Products in South Africa (ANHP) on 11 April 2022. SAHPRA is studying this judgement and consulting...
08 Apr SAHPRA CT Office Relocation
08 April 2022 The South African Health Products Regulatory Authority (SAHPRA) office in Cape Town has relocated from Bellville to Tyger Valley. The new office will be located at: North BlockAvanti Towers Office Park35 Carl Cronje DriveTyger Falls The new office will be accessible from Monday, 11 April 2022. We...
08 Apr SAHPRA Responds to claims that hawkers are selling illicit medication in Cape Town
08 April 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) remains committed in protecting the public from the supply of counterfeit and substandard medicines. Following the media report by eNCA claiming that some hawkers in Cape Town were illegally selling medicines, SAHPRA worked...
08 Apr SAHPRA Industry workshop
Posted at 10:51h
in
The purposes of the webinar are to provide clarification on the responsibilities of SANAS and SAHPRA with regards to Conformity Assessment Bodies (CABs) operating in South Africa and to have a discussion on the renewal process and expectations from the industry and SAHPRA. Date: Thursday, 14...
13 Mar Vaccine Safety: Side Effects & Adverse Events Following Immunisation (AEFIs) Webinar
Posted at 12:58h
in
As part of its ongoing response to COVID-19 communications and following a series of successful public events, the South African Health Products Regulatory Authority (SAHPRA) will be hosting a Webinar on “Vaccine Safety and Adverse Events”. The propose of the Webinar is to provide a...
11 Mar SAHPRA clarifies the risks and benefits of the Pfizer Comirnaty vaccine
11 March 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) has noted that a safety report in relation to the COVID-19 Pfizer Comirnaty vaccine directed to the United States Food and Drug Administration (FDA) has been distributed on various communication platforms in South...
17 Feb SAHPRA has authorised access to molnupiravir
17 February 2022 Embargo: Immediate release Until recently, the treatment options for patients with mild-to-moderate COVID-19 have been limited. New oral antiviral medicines are becoming available for the treatment of confirmed COVID-19 in adults who do not require supplemental oxygen and who are at risk of...
07 Feb SAHPRA registers two COVID-19 vaccines
adria Crehuet Cano via Unsplash...